These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32464592)

  • 1. Conformational selection is present in ligand binding to cytochrome P450 19A1 lipoprotein nanodiscs.
    Zárate-Pérez F; Hackett JC
    J Inorg Biochem; 2020 Aug; 209():111120. PubMed ID: 32464592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small angle scattering reveals the orientation of cytochrome P450 19A1 in lipoprotein nanodiscs.
    Hackett JC; Krueger S; Urban VS; Zárate-Pérez F
    J Inorg Biochem; 2024 Aug; 257():112579. PubMed ID: 38703512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector role of cytochrome P450 reductase for androstenedione binding to human aromatase.
    Zhang C; Catucci G; Di Nardo G; Gilardi G
    Int J Biol Macromol; 2020 Dec; 164():510-517. PubMed ID: 32698066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of variations in human P450 oxidoreductase on the aromatase activity of CYP19A1 polymorphisms R264C and R264H.
    Parween S; DiNardo G; Baj F; Zhang C; Gilardi G; Pandey AV
    J Steroid Biochem Mol Biol; 2020 Feb; 196():105507. PubMed ID: 31669572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of cholesterol on kinetic parameters for human aromatase (P450 19A1) in phospholipid nanodiscs.
    Sumangala N; Im SC; Valentín-Goyco J; Auchus RJ
    J Inorg Biochem; 2023 Oct; 247():112340. PubMed ID: 37544101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics and Mechanism of Binding of Androstenedione to Membrane-Associated Aromatase.
    Paço L; Zarate-Perez F; Clouser AF; Atkins WM; Hackett JC
    Biochemistry; 2020 Aug; 59(33):2999-3009. PubMed ID: 32786398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for an elevated aspartate pK(a) in the active site of human aromatase.
    Di Nardo G; Breitner M; Bandino A; Ghosh D; Jennings GK; Hackett JC; Gilardi G
    J Biol Chem; 2015 Jan; 290(2):1186-96. PubMed ID: 25425647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytochrome P450 enzymes bind drugs and other substrates mainly through conformational-selection modes.
    Guengerich FP; Wilkey CJ; Phan TTN
    J Biol Chem; 2019 Jul; 294(28):10928-10941. PubMed ID: 31147443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic analysis of the three-step steroid aromatase reaction of human cytochrome P450 19A1.
    Sohl CD; Guengerich FP
    J Biol Chem; 2010 Jun; 285(23):17734-43. PubMed ID: 20385561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human placental estrogen synthetase (aromatase). Effect of environment on the kinetics of protein-protein and substrate-protein interactions and the production of 19-oxygenated androgen intermediates in the purified reconstituted cytochrome P450 enzyme system.
    Sethumadhavan K; Bellino FL
    J Steroid Biochem Mol Biol; 1991 Sep; 39(3):381-94. PubMed ID: 1911429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced Fit Describes Ligand Binding to Membrane-Associated Cytochrome P450 3A4.
    Sweeney DT; Zárate-Pérez F; Stokowa-Sołtys K; Hackett JC
    Mol Pharmacol; 2023 Oct; 104(4):154-163. PubMed ID: 37536953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone complex and non-steroidal ligands of human aromatase.
    Ghosh D; Egbuta C; Lo J
    J Steroid Biochem Mol Biol; 2018 Jul; 181():11-19. PubMed ID: 29476820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biophysical characterization of Aptenodytes forsteri cytochrome P450 aromatase.
    Zarate-Perez F; Velázquez-Fernández JB; Jennings GK; Shock LS; Lyons CE; Hackett JC
    J Inorg Biochem; 2018 Jul; 184():79-87. PubMed ID: 29684698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QM/MM modeling of the hydroxylation of the androstenedione substrate catalyzed by cytochrome P450 aromatase (CYP19A1).
    Viciano I; Castillo R; Martí S
    J Comput Chem; 2015 Sep; 36(23):1736-47. PubMed ID: 26096372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of Ferric Peroxide Anion Intermediates (Fe
    Tateishi Y; McCarty KD; Martin MV; Yoshimoto FK; Guengerich FP
    Angew Chem Int Ed Engl; 2024 Aug; 63(33):e202406542. PubMed ID: 38820076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational selection dominates binding of steroids to human cytochrome P450 17A1.
    Guengerich FP; Wilkey CJ; Glass SM; Reddish MJ
    J Biol Chem; 2019 Jun; 294(26):10028-10041. PubMed ID: 31072872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enolization as an alternative proton delivery pathway in human aromatase (P450 19A1).
    Krámos B; Oláh J
    J Phys Chem B; 2014 Jan; 118(2):390-405. PubMed ID: 24369956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raman evidence for specific substrate-induced structural changes in the heme pocket of human cytochrome P450 aromatase during the three consecutive oxygen activation steps.
    Tosha T; Kagawa N; Ohta T; Yoshioka S; Waterman MR; Kitagawa T
    Biochemistry; 2006 May; 45(17):5631-40. PubMed ID: 16634644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics and flexibility of human aromatase probed by FTIR and time resolved fluorescence spectroscopy.
    Di Nardo G; Breitner M; Sadeghi SJ; Castrignanò S; Mei G; Di Venere A; Nicolai E; Allegra P; Gilardi G
    PLoS One; 2013; 8(12):e82118. PubMed ID: 24349198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of intermediates and isotopically sensitive enolization distinguish between aromatase (cytochrome P450 CYP19) from rat ovary and human placenta.
    Swinney DC; Watson DM; So OY
    Arch Biochem Biophys; 1993 Aug; 305(1):61-7. PubMed ID: 8342956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.